Document Detail

A Tri-copper(II) Complex Displaying DNA-Cleaving Properties and Antiproliferative Activity Against Cancer Cells.
MedLine Citation:
PMID:  23059789     Owner:  NLM     Status:  Publisher    
A new disubstituted terpyridine ligand and the corresponding tri-copper(II) complex have been prepared and characterised. The binding affinity and binding mode of this tri-copper complex (as well as the previously reported mono- and di-copper analogues) towards duplex DNA were determined by using UV/Vis spectroscopic titrations and fluorescent indicator displacement (FID) assays. These studies showed the three complexes to bind moderately (in the order of 10(4)  M(-1) ) to duplex DNA (ct-DNA and a 26-mer sequence). Furthermore, the number of copper centres and the nature of the substituents were found to play a significant role in defining the binding mode (intercalative or groove binding). The nuclease potential of the three complexes was investigated by using circular plasmid DNA as a substrate and analysing the products by agarose-gel electrophoresis. The cleaving activity was found to be dependent on the number of copper centres present (cleaving potency was in the order: tri-copper>di-copper>mono-copper). Interestingly, the tri-copper complex was able to cleave DNA without the need of external co-reductants. As this complex displayed the most promising nuclease properties, cell-based studies were carried out to establish if there was a direct link between DNA cleavage and cellular toxicity. The tri-copper complex displayed high cytotoxicity against four cancer cell lines. Of particular interest was that it displayed high cytotoxicity against the cisplatin-resistant MOLT-4 leukaemia cell line. Cellular uptake studies showed that the tri-copper complex was able to enter the cell and more importantly localise in the nucleus. Immunoblotting analysis (used to monitor changes in protein levels related to the DNA damage response pathway) and DNA-flow cytometric studies suggested that this tri-copper(II) complex is able to induce cellular DNA damage.
Kogularamanan Suntharalingam; Douglas J Hunt; Alexandra A Duarte; Andrew J P White; David J Mann; Ramon Vilar
Related Documents :
2066099 - Screening for a prevalent ldl receptor mutation in patients with severe hypercholestero...
23434229 - Synthesis, crystal structures, dna binding and cytotoxicity of two novel platinum(ii) c...
22324639 - Kinetic analysis of the bypass of a bulky dna lesion catalyzed by human y-family dna po...
12116849 - Persistence of human parvovirus b19 in human tissues.
22517059 - Greater nucleic acids oxidation in the temporal lobe than the frontal lobe in samp8.
23494169 - Fluorescence spectroscopic and calorimetry based approaches to characterize the mode of...
7183679 - Repair of o6-methyl-guanine residues in dna takes place by a similar mechanism in extra...
3168159 - Intracellular 58-kd selenoprotein levels correlate with inhibition of dna synthesis in ...
11432839 - Human telomerase contains two cooperating telomerase rna molecules.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-11
Journal Detail:
Title:  Chemistry (Weinheim an der Bergstrasse, Germany)     Volume:  -     ISSN:  1521-3765     ISO Abbreviation:  Chemistry     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9513783     Medline TA:  Chemistry     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Department of Chemistry, Imperial College London, South Kensington, London SW7 2AZ (UK), Fax: (+44) 2075-941139.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previ...
Next Document:  No beneficial effect of intrathecal methylprednisolone acetate in postherpetic neuralgia patients.